Save

Streptococcus thermophilus fermented milk reduces serum MDA-LDL and blood pressure in healthy and mildly hypercholesterolaemic adults

In: Beneficial Microbes
Authors:
M. Ito Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo, 186-8650 Japan.

Search for other papers by M. Ito in
Current site
Google Scholar
PubMed
Close
,
S. Kusuhara Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo, 186-8650 Japan.

Search for other papers by S. Kusuhara in
Current site
Google Scholar
PubMed
Close
,
W. Yokoi Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo, 186-8650 Japan.

Search for other papers by W. Yokoi in
Current site
Google Scholar
PubMed
Close
,
T. Sato Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo, 186-8650 Japan.

Search for other papers by T. Sato in
Current site
Google Scholar
PubMed
Close
,
H. Ishiki 2Development Department, Yakult Honsha Co., Ltd., 1-1-19 Higashi-shinbashi, Minato-ku, Tokyo, 105-8660 Japan.

Search for other papers by H. Ishiki in
Current site
Google Scholar
PubMed
Close
,
S. Miida 2Development Department, Yakult Honsha Co., Ltd., 1-1-19 Higashi-shinbashi, Minato-ku, Tokyo, 105-8660 Japan.

Search for other papers by S. Miida in
Current site
Google Scholar
PubMed
Close
,
A. Matsui 2Development Department, Yakult Honsha Co., Ltd., 1-1-19 Higashi-shinbashi, Minato-ku, Tokyo, 105-8660 Japan.

Search for other papers by A. Matsui in
Current site
Google Scholar
PubMed
Close
,
K. Nakamori 2Development Department, Yakult Honsha Co., Ltd., 1-1-19 Higashi-shinbashi, Minato-ku, Tokyo, 105-8660 Japan.

Search for other papers by K. Nakamori in
Current site
Google Scholar
PubMed
Close
,
C. Nonaka 2Development Department, Yakult Honsha Co., Ltd., 1-1-19 Higashi-shinbashi, Minato-ku, Tokyo, 105-8660 Japan.

Search for other papers by C. Nonaka in
Current site
Google Scholar
PubMed
Close
, and
K. Miyazaki Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo, 186-8650 Japan.

Search for other papers by K. Miyazaki in
Current site
Google Scholar
PubMed
Close
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

Low-density lipoprotein (LDL)-cholesterol, malondialdehyde-modified low-density lipoprotein (MDA-LDL), MDA-LDL/LDL-cholesterol in serum, and blood pressure are considered useful risk markers of cardiovascular diseases. This study aimed to examine whether a fermented milk containing Streptococcus thermophilus YIT 2001 (ST), which has high anti-oxidative activity, would benefit healthy and mildly hyper-LDL-cholesterolaemic adults via a randomised, double-blind, placebo-controlled trial. ST-fermented milk or non-fermented placebo milk (PC) was consumed once a day for 12 weeks by 29 and 30 subjects, respectively, with average serum LDL-cholesterol levels of about 140 mg/dl. Serum levels of LDL-cholesterol and MDA-LDL and blood pressure were analysed before (baseline) and after consumption. Comparisons of the responses between both groups were assessed using analysis of covariance (ANCOVA, with the baseline value as the covariate). ANCOVA demonstrated that the ST group had significant reductions in MDA-LDL, MDA-LDL/LDL-cholesterol, systolic blood pressure (SBP), and diastolic blood pressure (DBP) compared with the PC group during the consumption period (P<0.05). Moreover, stratified analysis revealed that there were significant reductions in MDA-LDL, MDA-LDL/LDL-cholesterol, SBP, and DBP in the ST group compared with the PC group during the consumption period in subjects who had above median (65 U/l) levels of oxidative stress marker MDA-LDL at baseline (P<0.05), but not in subjects with levels below the median. These findings suggest that daily consumption of ST-fermented milk may be beneficial in healthy or mildly hyper-LDL cholesterolaemic subjects through reductions in risk marker values of oxidative stress and/or cardiovascular diseases. The benefits were particularly remarkable in subjects who had higher levels of MDA-LDL.

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 385 320 25
Full Text Views 14 7 2
PDF Views & Downloads 22 18 4